Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects

Clinical trial NCT07246252 · COMPLETED

Trial details

NCT number: NCT07246252
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers (HV)

Start date: 2024-03-28
Primary completion: 2024-09-30
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.